The clinical and cost effectiveness of footwear and orthotic therapy in the management of the neuropathic diabetic foot - a single blind randomised controlled trial

ISRCTN ISRCTN87231372
DOI https://doi.org/10.1186/ISRCTN87231372
Secondary identifying numbers N0184175869
Submission date
29/09/2006
Registration date
29/09/2006
Last edited
29/03/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mrs Joanne Paton
Scientific

FF21 Peninsula Allied Health Centre
University of Plymouth
Derriford Road
Plymouth
PL6 9BH
United Kingdom

Phone +44 1752 238845
Email joanne.paton@plymouth.ac.uk

Study information

Study designSingle blind randomised controlled trial.
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study objectivesTo determine whether therapeutic shoes used with 2 types of inserts reduce peak pressure in the at-risk diabetic foot, and to determine which of the orthotics is most effective.
Ethics approval(s)Added 29 July 2008:
Ethical approval was granted by Cornwall and Plymouth Research Ethics Committee on 24/01/2006, prior to the commencement of recruitment.
Health condition(s) or problem(s) studiedNutritional, Metabolic, Endocrine: Diabetes
InterventionThe participants will be taken from both referrals and the existing caseload of the North and East Cornwall PCT Podiatry Service and Plymouth PCT podiatry service. Each participant will be required to complete a questionnaire and sign a consent form before taking part in the study. Each participant will receive a diabetic assessment of the lower limb to determine if they present with an increased risk of foot ulceration. Identification of the increased-risk foot include a neurological foot assessment. Each participant will be randomly assigned to one of two groups:
Group 1 will receive 2 pairs of orthopaedic shoes and a custom made moulded insert
Group 2 will receive 2 pairs of orthopaedic shoes and inlay
Intervention typeOther
Primary outcome measurePlantar peak pressure for the entire plantar surface during the stance phase of gait.
Secondary outcome measuresAdded 29 July 2008:
1. Forefoot pressure time integral
2. Total contact area
3. Rate of forefoot loading
4. Duration of load as a percentage of stance
5. Perceived foot health
6. Quality of life
7. Cost
Overall study start date03/03/2006
Completion date02/03/2008

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsSample size estimate n=130. 65 participants in each group.
Key inclusion criteria1. The subject must be diagnosed as type I or II diabetic
2. The subject must be identified as neuropathic and at risk of ulceration
3. The subject must not currently be suffering from any lower limb vascular or neuropathic ulceration identified by scoring Grade 0 on the Wagner classification for foot ulcer
4. The subject must be ambulant. Must be able to walk a minimum of approximately 10 metres unaided
5. The subject must be willing to comply with the requirements of the study
Key exclusion criteria1. Subjects with current ulceration or recently healed less than 6 months prior to enrolling onto the study (as the focus of the study is preventative ulcer management rather than treatment)
2. Subjects with severe fixed midfoot or rearfoot deformity ie Charcot joint (subjects would be unsuitable for prefabricated insoles and non-bespoke footwear)
3. Subjects with a history of bone and joint surgery of the lower limb including amputation (could lead to alteration in gait kinetics and may not be suitable for non bespoke insoles and footwear)
4. Subjects lacking the ability to comprehend simple instructions and comply with the study protocols and procedures (including those not able to read printed English)
5. Allied Health Professional students as they may be considered to have a dependant relationship with the investigator
6. Subjects diagnosed as neuropathic caused by pathology other than diabetes
Date of first enrolment03/03/2006
Date of final enrolment02/03/2008

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

FF21 Peninsula Allied Health Centre
Plymouth
PL6 9BH
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Government

The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Plymouth Primary Care Trust - Exeter PCT (UK) NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Other publications systematic review 01/01/2011 Yes No